DNA Vaccines — Designer Vaccines for the 21st Century
The DOI matches its Crossref record.
Abstract
Over the past 100 years, the development and widespread use of vaccines against infectious agents has been one of the triumphs of medical science. One reason for the success of these vaccines is that they excel at inducing antibodies, which are the principal agents of immune protection against most viruses and bacteria. There are, however, exceptions, including medically important intracellular organisms like Mycobacterium tuberculosis, the malarial parasite, Leishmania major, and possibly the human immunodeficiency virus (HIV), in which protection depends more on cell-mediated immunity than on the induction of antibodies (humoral immunity).All currently licensed vaccines, whether they are prepared . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Leishmaniasis: Current Status of Vaccine Development
Handman, E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.229-243.2001 · Cited by 600
Vaccines against intracellular infections requiring cellular immunity
Seder, R. A., & Hill, A. V. S. (2000) · Nature · doi:10.1038/35021239 · Cited by 394
Self-citationRecent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Yavchitz, A., Boutron, I., Bafeta, A., Marroun, I., Charles, P., Mantz, J., & Ravaud, P. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001308 · Cited by 293
Current Developments in Cancer Vaccines and Cellular Immunotherapy
Ribas, A., Butterfield, L. H., Glaspy, J. A., & Economou, J. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.041 · Cited by 295
Metadata
- Authors
- Seder, R. A., & Gurunathan, S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1999-07-22
- Volume
- 341
- Issue
- 4
- Pages
- 277-278
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1973830694
- Cited by
- 64
- References
- 0
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DNA Vaccines — Designer Vaccines for the 21st Century. https://app.cochat.ai/papers/10.1056/nejm199907223410410
- The paper
- Seder, R. A., & Gurunathan, S. (1999). DNA Vaccines — Designer Vaccines for the 21st Century. New England Journal of Medicine. https://doi.org/10.1056/nejm199907223410410
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.